|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cardiovascular Diseases | |||||
| Cerebral Anoxia | |||||
| Cerebrovascular Disorders | |||||
| Defect, Congenital Heart | |||||
| Heart Diseases | |||||
| Transposition of Great Vessels | |||||
| Heart Septal Defects, Ventricular | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Congenital Abnormalities | |||||
| Heart Defects, Congenital | |||||
| Heart Septal Defects | |||||
| Hypoxia, Brain | |||||
| 3 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Cardiovascular Abnormalities | |||||
| Central Nervous System Diseases | |||||
| Nervous System Diseases | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| cardiac surgical procedures | |||||
| cardiopulmonary bypass | |||||
| 5 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||